(Q42997080)

English

Evaluation of clinical usefulness of second-generation HCV core antigen assay: comparison with COBAS AMPLICOR HCV MONITOR assay version 2.0.

scientific article published in December 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Evaluation of clinical usefulness of second-generation HCV core antigen assay: comparison with COBAS AMPLICOR HCV MONITOR assay version 2.0. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

author name string

Osamu Yokosuka

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Shigenobu Kawai

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Yoichi Suzuki

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Kenichi Fukai

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Fumio Imazeki

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Tatsuo Kanda

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Motohisa Tada

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Rintarou Mikata

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Akira Hata

9

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hiromitsu Saisho

10

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

publication date

1 December 2005

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Liver International

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1136-1141

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01185.X

21 January 2018

Detection of hepatitis C virus specific core protein in serum of patients by a sensitive fluorescence enzyme immunoassay (FEIA).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01185.X

21 January 2018

Evaluation of the clinical usefulness of COBAS AMPLICOR HCV MONITOR assay (ver2.0): Comparison with AMPLICOR HCV MONITOR assay (ver1.0) and HCV core protein level

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01185.X

21 January 2018

Mucosal immunity and primary biliary cirrhosis: presence of antimitochondrial antibodies in urine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01185.X

21 January 2018

Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01185.X

21 January 2018

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01185.X

21 January 2018

Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01185.X

21 January 2018

Predictors of the efficacy of interferon therapy in chronic hepatitis C virus infection. Tokyo-Chiba Hepatitis Research Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01185.X

21 January 2018

A second group of hepatitis C viruses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01185.X

21 January 2018

Significance of specific antibody assay for genotyping of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01185.X

21 January 2018

What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01185.X

21 January 2018

Nonenveloped Nucleocapsids of Hepatitis C Virus in the Serum of Infected Patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01185.X

21 January 2018

Identifiers

10.1111/J.1478-3231.2005.01185.X

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42997080&oldid=1592123680"